{"id":"https://openalex.org/W154290000","doi":null,"title":"Characterization of binding sites for 3H-spiroperidol in human retina.","display_name":"Characterization of binding sites for 3H-spiroperidol in human retina.","publication_year":1988,"publication_date":"1988-05-01","ids":{"openalex":"https://openalex.org/W154290000","mag":"154290000","pmid":"https://pubmed.ncbi.nlm.nih.gov/2452802"},"language":"en","primary_location":{"id":"pmid:2452802","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2452802","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative ophthalmology & visual science","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034607026","display_name":"Paul McGonigle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P McGonigle","raw_affiliation_strings":["Department of Pharmacology, University of Pennsylvania, School of Medicine, Philadelphia 19104-6084"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Pennsylvania, School of Medicine, Philadelphia 19104-6084","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033711503","display_name":"Martin B. Wax","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M B Wax","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110320353","display_name":"Perry B. Molinoff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P B Molinoff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0541,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.75154189,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"5","first_page":"687","last_page":"94"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9502000212669373,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.037700001150369644,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/spiperone","display_name":"spiperone","score":0.8679999709129333},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.8379999995231628},{"id":"https://openalex.org/keywords/human-retina","display_name":"human retina","score":0.878000020980835},{"id":"https://openalex.org/keywords/binding-sites","display_name":"binding sites","score":0.6190000176429749},{"id":"https://openalex.org/keywords/butaclamol","display_name":"butaclamol","score":0.8149999976158142},{"id":"https://openalex.org/keywords/guanosine-triphosphate","display_name":"GTP","score":0.6340000033378601},{"id":"https://openalex.org/keywords/adenylate-cyclase-coupling","display_name":"adenylate cyclase coupling","score":0.9190000295639038},{"id":"https://openalex.org/keywords/hill-coefficient","display_name":"Hill coefficient","score":0.7139999866485596},{"id":"https://openalex.org/keywords/receptor-heterogeneity","display_name":"receptor heterogeneity","score":0.7149999737739563},{"id":"https://openalex.org/keywords/sulpiride","display_name":"sulpiride","score":0.5950000286102295},{"id":"https://openalex.org/keywords/fluphenazine","display_name":"fluphenazine","score":0.953000009059906},{"id":"https://openalex.org/keywords/ketanserin","display_name":"ketanserin","score":0.7630000114440918},{"id":"https://openalex.org/keywords/serotonin-receptors","display_name":"serotonin receptors","score":0.5289999842643738}],"concepts":[{"id":"https://openalex.org/C118716","wikidata":"https://www.wikidata.org/wiki/Q5514725","display_name":"GTP'","level":3,"score":0.7709733843803406},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.6515055894851685},{"id":"https://openalex.org/C2781073084","wikidata":"https://www.wikidata.org/wiki/Q3077150","display_name":"Spiperone","level":4,"score":0.6487493515014648},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5423151254653931},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5146675705909729},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4727169871330261},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42412662506103516},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3493742346763611},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3354445993900299},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32394877076148987},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24181127548217773},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1812477707862854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002069","descriptor_name":"Butaclamol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002069","descriptor_name":"Butaclamol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004294","descriptor_name":"Domperidone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004294","descriptor_name":"Domperidone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006160","descriptor_name":"Guanosine Triphosphate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006160","descriptor_name":"Guanosine Triphosphate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007650","descriptor_name":"Ketanserin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007650","descriptor_name":"Ketanserin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012160","descriptor_name":"Retina","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014316","descriptor_name":"Tritium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2452802","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2452802","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigative ophthalmology & visual science","raw_type":"Journal Article"},{"id":"mag:154290000","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2452802","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.504800021648407}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W629275675","https://openalex.org/W1983649348","https://openalex.org/W2002486079","https://openalex.org/W2021314674"],"related_works":["https://openalex.org/W13555360","https://openalex.org/W2055151678","https://openalex.org/W2028178449","https://openalex.org/W2468188152","https://openalex.org/W1984373575","https://openalex.org/W2260493179","https://openalex.org/W2039636395","https://openalex.org/W2035563106","https://openalex.org/W2053234111","https://openalex.org/W2076222200"],"abstract_inverted_index":{"Binding":[0],"sites":[1,177,206,229],"for":[2,77,122,142,182,199,211,249],"the":[3,16,31,58,61,72,82,85,91,106,115,125,146,166,176,185,192,217,238,241],"D-2-selective":[4],"antagonist":[5,243],"(3H)-spiroperidol":[6,34],"were":[7,136,162],"characterized":[8],"in":[9,15,36,145,184,216],"human":[10],"retina.":[11],"Nonspecific":[12],"binding,":[13],"measured":[14],"presence":[17,147,167,186,218],"of":[18,25,30,33,44,51,57,60,63,93,105,114,124,148,153,168,171,175,187,205,219,225,228,231,252],"2":[19],"microM":[20,95],"(+)-butaclamol,":[21],"made":[22],"up":[23],"20%":[24],"total":[26],"binding.":[27],"Scatchard":[28],"analysis":[29,152],"binding":[32,62,172],"resulted":[35],"linear":[37],"plots":[38],"and":[39,47,84,101,132,189,191,214],"yielded":[40],"a":[41,48,179,196,208,246],"Kd":[42],"value":[43,50],"87":[45],"pM":[46],"Bmax":[49],"1500":[52],"fmol/mg":[53],"protein.":[54],"In":[55],"studies":[56],"inhibition":[59,75,113,120,160],"(3H)-spiroperidol,":[64],"(+)-butaclamol":[65],"was":[66,79,88,99,234],"approximately":[67],"1000-fold":[68],"more":[69],"potent":[70],"than":[71,140],"(-)-stereoisomer.":[73],"The":[74,119,202,221],"curve":[76],"dopamine":[78,183],"shifted":[80],"to":[81,110],"right":[83],"Hill":[86,128,134],"coefficient":[87],"increased":[89],"by":[90,165,237],"addition":[92],"300":[94],"GTP.":[96,149,220],"This":[97],"effect":[98],"agonist-specific":[100],"suggests":[102],"that":[103,157,223,240],"some":[104],"receptors":[107,233],"are":[108],"coupled":[109],"stimulation":[111],"or":[112],"enzyme":[116],"adenylate":[117],"cyclase.":[118],"curves":[121,161],"most":[123],"antagonists":[126],"had":[127,207,245],"coefficients":[129,135],"between":[130],"0.6":[131],"0.8.":[133],"also":[137],"consistently":[138],"less":[139],"1.0":[141],"agonists":[143],"even":[144],"Nonlinear":[150],"regression":[151],"untransformed":[154],"data":[155],"revealed":[156],"these":[158,200,226],"shallow":[159],"best":[163],"explained":[164],"two":[169],"populations":[170],"sites,":[173],"40%":[174],"having":[178,195],"high":[180],"affinity":[181,198,210,248],"GTP":[188],"domperidone":[190],"remaining":[193],"60%":[194],"lower":[197],"ligands.":[201],"larger":[203],"population":[204],"higher":[209],"sulpiride,":[212],"fluphenazine,":[213],"N-propylnorapomorphine":[215],"possibility":[222],"either":[224],"classes":[227,251],"consisted":[230],"serotonin":[232],"ruled":[235],"out":[236],"finding":[239],"5-HT2":[242],"ketanserin":[244],"low":[247],"both":[250],"sites.":[253]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}